Image via Wikipedia
As you read the article from the National Post below, understand the underlying process taking place.
This is part of the UN/NWO/Elite/Banker/Corp plan for domination. This follows the UN plan for depopulation and bankrupting of people.
If you can’t access the medicines you require you obviously won’t live as long. If you own assets like property, you may be forced to sell to get money for medicine or medical treatment like an operation. Agenda 21 states that private property is not sustainable. What a great way to get you to give up your property…..something anyone would do to save their life.
Also understand, the gov could make available all medicine and operations if they wanted to. They unfortunately have bought into the UN/NWO/Corp agenda.
You are no longer a living breathing person, not in their eyes. You are a “human resource”, like any other resource, used for generation of corporate profit. When a resource costs a corporation money, it becomes a liability and is “risk managed.” If you become ill or have reached retirement age you become a liability.
This also reflects the UN Universal Human Rights Code which declares everyone has the right to adequate health-care. Problem-who decides what “adequate” is? You, your doctor, your employer or the UN and the Corporations?
It’s time to wake-up to the “new reality.”
Keep this in mind as you read the National Post story below-
A growing tide of high-priced specialty medicines for arthritis, cancer and other diseases is set to put unprecedented pressure on workplace drug plans, likely forcing strict limits on what they cover, higher employee premiums and even an end to some plans altogether, experts are warning.
The private benefit programs that millions of Canadians depend on are due for “radical change” that could force many to pay thousands of dollars out of pocket for their medications, one consultant planned to tell a conference Thursday of the Health Charities Coalition of Canada.
“I believe it’s going to move the employer drug plan into an era of unaffordability and unsustainability,”
David West of Mercer Human Resources Consulting said in an interview Wednesday. “I think it’s a critical issue. Unless all the players and stakeholders get together and develop a mutually beneficial process, it’s going to be difficult for a lot of individuals to access these meds.”
Even now, specialty drugs like Remicade — a “biologic” treatment for rheumatoid arthritis and Crohn’s disease — account for less than 1% of the number of claims to private insurance, and 16% of the total costs. A year’s worth of infusions can carry a price tag of close to $50,000.
One mid-size employer decided this week that its plan would no longer cover any biologics, said Mike Sullivan, president of Cubic Health, which advises employer benefit managers.
Mr. West said he has heard from other employers seeking to end their biologics coverage, too.
“It’s a massive issue that is really only starting to come to the surface now,” Mr. Sullivan said.
Mr. West said he first became aware of the issue about a year ago when he learned of a new biologic to treat Lupus. Very pricey, it was still likely to be relatively widely used.
Further research revealed 74 biologics and other speciality drugs for diseases such as arthritis, multiple sclerosis and Crohn’s far into the pipeline, plus 22 new cancer drugs that were late in the stage of development and would qualify for coverage under most private plans, said Mr. West.
He estimates that costs will soar by 2.5 to three fold by 2019 at the latest and possibly within the next three to four years. Benefits mangers are rattled by the fact many of the high-cost medications are for ongoing, long-term treatment of conditions, rather than, say, an expensive cancer drug that may only be needed for a few months.
Some plans are already reporting claims of $650,000 a year for Soliris, a drug to tread a rare blood disorder, Mr. West said.
Meanwhile, those savings from generic drugs are disproportionately benefiting government drug programs that mostly cover the elderly, said Mr. Sullivan. Many of the new specialty medications will be used more by people in their working years, covered by employer plans, he said. And those products average about $1,500 a claim, versus $50 a claim for the standard type of medication.
The result is likely to be restrictions on what is covered and overall caps on how much each employee can claim, said Mr. Sullivan. Mr. West said it is possible some drug plans will be cancelled entirely.
“We’re moving into an era where, if the drug spend rises too high, too quickly, employers will likely take drastic action,” he said.
Mr. West suggested that plans will have to take more measures to control costs, such as ensuring that medical guidelines are followed, which can mean reserving the new, high-cost drugs as last-ditch treatments.
Not convinced? Read on……..
For environmentally sustainable populations
Too Many Canadians?
In Canada many believe there is an abundance of resources and endless space for more and more people. But, numbers are growing by nearly 1% a year and non-renewable resources diminishing. In the densely populated southern tier where 90% live, urban congestion, environmental pollution and social challenges associated with crowded living conditions are a growing reality. Ecosystems face increased pressures as we devour our best farmlands and forests, pollute the waters we drink and the air we breathe, in the process hastening the pace of habitat destruction, biodiversity loss and climate change.
Too Large a Footprint
With one of the largest per capita ecological footprints in the world, Canadians can no longer ignore the negative impact of our population growth on the environment.
World Bank United Nations Monsanto global food agenda population control
Bill Gates – Does He Want You Dead?
Dr. Arlene King – Is the H1N1 Flu a Hoax?
WHO memos 1972 explains how to turn vaccines into a means of killing
H1N1 Vaccine with Mercury and Squalene Pushed on Pregnant Women
Bill Ryerson – Global Population Speakout
Horrors of Vaccination Exposed and Illustrated